DGCR6L Human

DiGeorge Syndrome Critical Region Gene 6-Like Human Recombinant
Cat. No.
BT30580
Source
Escherichia Coli.
Synonyms
Protein DGCR6L, DiGeorge syndrome critical region 6-like protein, DGCR6L.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 85.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

DGCR6L Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 243 amino acids (1-220 a.a) and having a molecular mass of 27.3kDa.
DGCR6L is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
The DiGeorge syndrome critical region 6-like protein (DGCR6L) exhibits homology with both the Drosophila gonadal protein, suggesting a role in gonadal tissues and germ cells, and the human laminin gamma-1 chain, which is involved in cell adhesion and movement. Located on chromosome 22 within a region linked to DiGeorge syndrome, DGCR6L is implicated in the CATCH 22 syndrome, a broader spectrum of abnormalities. Furthermore, DGCR6L is one of two functional genes encoding structurally similar proteins with comparable expression profiles.
Description
Recombinant human DGCR6L, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 243 amino acids (residues 1-220) with a molecular weight of 27.3 kDa. The protein includes a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
DGCR6L protein is supplied at a concentration of 0.5 mg/ml in a solution containing 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 50% glycerol, 1 mM DTT, and 250 mM imidazole.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended periods, storage at -20°C is recommended. To enhance stability during long-term storage, the addition of a carrier protein (0.1% HSA or BSA) is advisable. Repeated freeze-thaw cycles should be avoided.
Purity
Purity exceeds 85.0% as assessed by SDS-PAGE analysis.
Synonyms
Protein DGCR6L, DiGeorge syndrome critical region 6-like protein, DGCR6L.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMERYAAA LEEVADGARQ QERHYQLLSA LQSLVKELPS SFQQRLSYTT LSDLALALLD GTVFEIVQGL LEIQHLTEKS LYNQRLRLQN EHRVLRQALR QKHQEAQQAC RPHNLPVVQA AQQRELEAVE HRIREEQRAM DQKIILELDR KVADQQSTLE KAGVAGFYVT TNPQELMLQM NLLELIRKLQ QRGCRAGNAA LGLGGPWQSP AAQCDQKGSP VPP.

Product Science Overview

Introduction

DiGeorge Syndrome Critical Region Gene 6-Like (DGCR6L) is a gene located on chromosome 22q11.21. This gene is part of a region implicated in DiGeorge syndrome, a disorder characterized by congenital heart defects, facial dysmorphisms, and immune deficiencies. DGCR6L is one of two functional genes resulting from a duplication event, with its counterpart being DGCR6 .

Gene Structure and Expression

DGCR6L and DGCR6 share a high degree of similarity, with their proteins being nearly identical. Both genes consist of five exons with conserved intron/exon structures . DGCR6L is expressed in various tissues, including the liver, heart, and skeletal muscle, but is notably absent in adult skeletal muscle and small intestine . The protein encoded by DGCR6L is involved in cell attachment and migration, sharing homology with the Drosophila gonadal protein and the human laminin gamma-1 chain .

Function and Role in Disease

The DGCR6L protein is believed to play a role in neural crest cell migration into the third and fourth pharyngeal pouches, which is crucial for the development of several structures in the body . Mutations or deletions in the DGCR6L gene can contribute to the phenotypic manifestations of DiGeorge syndrome and other related disorders, such as velocardiofacial syndrome .

Evolutionary Perspective

The duplication event that gave rise to DGCR6L and DGCR6 is estimated to have occurred at least 12 million years ago, possibly before the divergence of Catarrhines from Platyrrhines, around 35 million years ago . This suggests that there has been selective evolutionary pressure to maintain the functional integrity of both paralogs.

Clinical Significance

DGCR6L is associated with several diseases, including prostate cancer and DiGeorge syndrome . The protein’s expression levels are elevated in various human tumor cell lines, indicating its potential role in cancer biology . Understanding the function and regulation of DGCR6L can provide insights into the molecular mechanisms underlying these diseases and aid in the development of targeted therapies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.